SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-239699
Filing Date
2018-08-06
Accepted
2018-08-06 16:17:06
Documents
3
Period of Report
2018-08-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d596388d8k.htm 8-K 15815
2 EX-99.1 d596388dex991.htm EX-99.1 20218
3 GRAPHIC g596388g0806202930573.jpg GRAPHIC 3606
  Complete submission text file 0001193125-18-239699.txt   42261
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 18994947
SIC: 2834 Pharmaceutical Preparations